Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
It works as a GLP-1 receptor agonist, reducing appetite, slowing gastric emptying, and regulating blood glucose
You should seek urgent medical help if you develop symptoms that may indicate a serious reaction rather than expected treatment adjustment
Thyroid neoplasms
Day 1 starts at first use, and day 56 is the discard date
New Dosing Conversion (2026 Guide) If you are switching from the old formulation to the new round tablets, use this bioequivalence table: Benefits Improves blood sugar control in adults with type 2 diabetes Helps with weight loss by reducing hunger and cravings Convenient oral alternative to injectable semaglutide May reduce risk of cardiovascular events in eligible patients Simple once-daily dosing without needles Rybelsus contains semaglutide , a once-daily oral GLP-1 receptor agonist designed to improve blood sugar control in type 2 diabetes and support weight loss
US$ 21.98
US$ 28.51
US$ 23.86
US$ 27.09
US$ 25.13
